Capital Fund Management (CFM)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $27.3M | Buy |
973,300
+284,300
| +41% | +$7.57M | 0.12% | 213 |
|
|
2025
Q4 | $17.2M | Sell |
689,000
-1,328,700
| -66% | -$33.5M | 0.05% | 561 |
|
|
2025
Q3 | $51.4M | Sell |
2,017,700
-1,321,500
| -40% | -$32.6M | 0.13% | 185 |
|
|
2025
Q2 | $80.9M | Buy |
3,339,200
+1,533,200
| +85% | +$35.8M | 0.22% | 94 |
|
|
2025
Q1 | $45.8M | Buy |
1,806,000
+432,900
| +32% | +$11.3M | 0.13% | 223 |
|
|
2024
Q4 | $36.4M | Sell |
1,373,100
-594,700
| -30% | -$16.1M | 0.09% | 304 |
|
|
2024
Q3 | $56.9M | Sell |
1,967,800
-932,400
| -32% | -$27.2M | 0.16% | 172 |
|
|
2024
Q2 | $81.1M | Sell |
2,900,200
-1,171,800
| -29% | -$32.3M | 0.24% | 108 |
|
|
2024
Q1 | $113M | Sell |
4,072,000
-613,600
| -13% | -$17M | 0.33% | 48 |
|
|
2023
Q4 | $135M | Buy |
4,685,600
+2,042,300
| +77% | +$61.7M | 0.36% | 37 |
|
|
2023
Q3 | $87.7M | Buy |
2,643,300
+792,300
| +43% | +$28M | 0.3% | 68 |
|
|
2023
Q2 | $67.9M | Buy |
1,851,000
+441,400
| +31% | +$17.2M | 0.28% | 82 |
|
|
2023
Q1 | $57.5M | Buy |
1,409,600
+683,400
| +94% | +$29.5M | 0.28% | 86 |
|
|
2022
Q4 | $37.2M | Sell |
726,200
-324,400
| -31% | -$15.6M | 0.25% | 92 |
|
|
2022
Q3 | $46M | Buy |
1,050,600
+123,100
| +13% | +$5.98M | 0.36% | 58 |
|
|
2022
Q2 | $48.6M | Sell |
927,500
-448,100
| -33% | -$22.8M | 0.44% | 33 |
|
|
2022
Q1 | $71.2M | Buy |
1,375,600
+331,800
| +32% | +$17.2M | 0.58% | 11 |
|
|
2021
Q4 | $61.6M | Buy |
1,043,800
+660,800
| +173% | +$32.7M | 0.44% | 20 |
|
|
2021
Q3 | $16.5M | Buy |
+383,000
| New | +$17M | 0.12% | 219 |
|
|
2021
Q1 | – | Sell |
-138,000
| Closed | -$5.08M | – | 1544 |
|
|
2020
Q4 | $5.08M | Sell |
138,000
-22,735
| -14% | -$834K | 0.05% | 454 |
|
|
2020
Q3 | $5.6M | Sell |
160,735
-127,534
| -44% | -$4.47M | 0.07% | 322 |
|
|
2020
Q2 | $8.94M | Sell |
288,269
-669,185
| -70% | -$22.7M | 0.14% | 210 |
|
|
2020
Q1 | $29.6M | Sell |
957,454
-536,064
| -36% | -$18.3M | 0.46% | 33 |
|
|
2019
Q4 | $55.5M | Sell |
1,493,518
-12,016
| -0.8% | -$428K | 0.44% | 43 |
|
|
2019
Q3 | $51.3M | Buy |
1,505,534
+997,401
| +196% | +$36.3M | 0.46% | 36 |
|
|
2019
Q2 | $20.9M | Sell |
508,133
-177,178
| -26% | -$7.04M | 0.19% | 143 |
|
|
2019
Q1 | $27.6M | Sell |
685,311
-932,790
| -58% | -$37.4M | 0.25% | 110 |
|
|
2018
Q4 | $67M | Buy |
1,618,101
+345,396
| +27% | +$14.3M | 0.59% | 15 |
|
|
2018
Q3 | $53.2M | Buy |
1,272,705
+912,237
| +253% | +$35.1M | 0.29% | 56 |
|
|
2018
Q2 | $12.4M | Sell |
360,468
-119,734
| -25% | -$4.09M | 0.06% | 412 |
|
|
2018
Q1 | $16.2M | Sell |
480,202
-900,854
| -65% | -$31M | 0.1% | 299 |
|
|
2017
Q4 | $47.5M | Buy |
1,381,056
+689,210
| +100% | +$23.5M | 0.26% | 94 |
|
|
2017
Q3 | $23.4M | Sell |
691,846
-18,234
| -3% | -$586K | 0.17% | 170 |
|
|
2017
Q2 | $22.6M | Sell |
710,080
-633,875
| -47% | -$20M | 0.18% | 157 |
|
|
2017
Q1 | $43.6M | Sell |
1,343,955
-1,003,935
| -43% | -$31.7M | 0.36% | 64 |
|
|
2016
Q4 | $72.4M | Buy |
2,347,890
+1,716,228
| +272% | +$52.4M | 0.62% | 18 |
|
|
2016
Q3 | $20.3M | Sell |
631,662
-488,002
| -44% | -$16.3M | 0.19% | 145 |
|
|
2016
Q2 | $37.4M | Buy |
1,119,664
+1,072,129
| +2,255% | +$34.2M | 0.35% | 69 |
|
|
2016
Q1 | $1.34M | Sell |
47,535
-375,857
| -89% | -$10.7M | 0.01% | 804 |
|
|
2015
Q4 | $13M | Sell |
423,392
-251,063
| -37% | -$7.9M | 0.13% | 213 |
|
|
2015
Q3 | $20.1M | Sell |
674,455
-84,214
| -11% | -$2.7M | 0.22% | 113 |
|
|
2015
Q2 | $24.1M | Sell |
758,669
-530,584
| -41% | -$17.3M | 0.31% | 77 |
|
|
2015
Q1 | $42.6M | Buy |
1,289,253
+1,178,161
| +1,061% | +$37.5M | 0.58% | 24 |
|
|
2014
Q4 | $3.28M | Sell |
111,092
-89,484
| -45% | -$2.57M | 0.04% | 550 |
|
|
2014
Q3 | $5.63M | Buy |
200,576
+146,822
| +273% | +$4.12M | 0.06% | 382 |
|
|
2014
Q2 | $1.51M | Sell |
53,754
-21,923
| -29% | -$625K | 0.02% | 817 |
|
|
2014
Q1 | $2.31M | Sell |
75,677
-211,538
| -74% | -$6.31M | 0.03% | 634 |
|
|
2013
Q4 | $8.35M | Buy |
287,215
+27,720
| +11% | +$807K | 0.1% | 240 |
|
|
2013
Q3 | $7.07M | Buy |
259,495
+85,901
| +49% | +$2.34M | 0.1% | 266 |
|
|
2013
Q2 | $4.61M | Buy |
+173,594
| New | +$4.8M | 0.07% | 378 |
|
Other funds holding PFE
VCM
VPM
Capital Fund Management (CFM)'s PFE Position: Q1 2026 in Review
Capital Fund Management (CFM) opened a new position in Pfizer (PFE) in Q1 2026: 264,357 shares worth $7.42M. The stake represents 0.03% of the portfolio and ranks #694 among its holdings. This is a return to the name: Capital Fund Management (CFM) previously reported a position in PFE as recently as Q3 2025.
Capital Fund Management (CFM) first reported a position in PFE in Q4 2013 and has held it in 35 quarters since. The position peaked at $58.5M in Q2 2014. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Capital Fund Management (CFM) held 264,357 shares of Pfizer worth $7.42M as of Q1 2026.
- Pfizer was a new Capital Fund Management (CFM) position in Q1 2026.
- Pfizer made up 0.03% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #694 holding.
- Capital Fund Management (CFM) first reported a position in Pfizer in Q4 2013 and has held it in 35 quarters since.
- Capital Fund Management (CFM)'s Pfizer position peaked at $58.5M in Q2 2014.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.